YELP INC·4

Feb 5, 5:43 PM ET

Stoppelman Jeremy 4

Research Summary

AI-generated summary

Updated

Yelp CEO Jeremy Stoppelman Exercises Options, Sells 66,200 Shares

What Happened

  • Jeremy Stoppelman, CEO of Yelp (YELP), exercised stock options totaling 66,200 shares at an exercise price of $20.47 per share and sold those same 66,200 shares in open-market transactions. He paid $1,355,114 to exercise the options and received aggregate sale proceeds of $1,678,961.
  • In addition, the filing shows awards of restricted stock units (RSUs): 152,573 RSUs that vest quarterly over four years (F1) and 55,796 performance-based RSUs that became eligible to vest based on achieved goals (F2) — together 208,369 award shares granted/acquired at $0.00 in the report.

Key Details

  • Transaction dates: exercises and sales occurred Feb 3–5, 2026; filing date: Feb 5, 2026 (Form 4 filed timely).
  • Exercise details: 30,000 shares on Feb 3, 30,000 on Feb 4, and 6,200 on Feb 5 at $20.47 each (total exercise cost $1,355,114).
  • Sales (open market): matched the exercised shares — 30,000 sold on Feb 3 (weighted avg prices reported), 30,000 on Feb 4, and 6,200 on Feb 5 — total proceeds $1,678,961. The filing reports weighted-average sale prices and price ranges for the multiple trades (see F4–F8).
  • Awards: 152,573 RSUs vesting quarterly over four years (F1); 55,796 performance-based RSUs became eligible to vest on Feb 20, 2026 subject to continued service (F2).
  • Sales executed pursuant to a pre-established 10b5-1 trading plan (F3).
  • Shares owned after the reported transactions: not specified in the Form 4 summary provided.

Context

  • This was effectively a cashless exercise: Stoppelman exercised options and sold the same shares immediately (exercise price paid and shares sold in the market).
  • RSU awards are granted at $0.00 but are subject to vesting and service/performance conditions and thus do not represent immediately liquid shares.
  • These are routine insider transactions (compensation-related exercises and planned sales under a 10b5-1 plan); the filing is factual and does not indicate insider sentiment.